We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Mobile 3-in-1 Imaging System Advances Intraoperative Navigation

By HospiMedica International staff writers
Posted on 09 Sep 2026

Globus Medical’s Excelsius3D intelligent 3-in-1 imaging system has received the CE Mark for commercial sale in the European Union and the United Kingdom. More...

The addition of Excelsius3D expands the company’s Excelsius Ecosystem of enabling technologies and enhances the capabilities of the ExcelsiusGPS robotic navigation system in Europe. The system is intended to support a connected platform for intraoperative imaging and guidance.

Excelsius3D is an intelligent, mobile imaging platform that combines 3D cone‑beam computed tomography (CT), 2D fluoroscopy, and digital radiography in a single system. Designed for intraoperative use, it integrates with ExcelsiusGPS so intraoperative imaging and robotic navigation work together within a streamlined procedural workflow. A compact footprint and omnidirectional wheels facilitate positioning and transport in the operating room while offering multiple imaging modalities in one platform.

Indications for use specify that Excelsius3D is a mobile X‑ray system designed for 2D fluoroscopy, 2D digital radiography, and 3D imaging of adult and pediatric patients. It is intended for situations in which physicians benefit from 2D and 3D information on anatomic structures and on high‑contrast, high‑attenuation objects such as bony anatomy and metallic objects. Acquired images are compatible with image‑guided systems such as ExcelsiusGPS.

With CE marking, commercialization of Excelsius3D will begin in the European Union and United Kingdom. The system previously received U.S. Food and Drug Administration (FDA) 510(k) clearance in 2021. As part of the Excelsius Ecosystem, it can function as a stand‑alone intraoperative imaging platform or as an integrated component working with ExcelsiusGPS.

“The CE mark for Excelsius3D represents an important milestone in the continued expansion of the Excelsius Ecosystem. We are committed to bringing innovative enabling technologies to surgeons around the world, and this important milestone further expands the capabilities of our platform by combining intraoperative imaging with the robotic navigation capabilities of ExcelsiusGPS across the European Union,” said Keith Pfeil, President and Chief Executive Officer of Globus Medical.

Related Links
Globus Medical


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hypodermic Syringe
SurTract™ Safety Syringe
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: A reusable, soft contact lens developed at the Terasaki Institute for Biomedical Innovation offers a noninvasive way to measure the stress-linked hormone serotonin directly from tears. (Image Credit: Terasaki Institute for Biomedical Innovation)

Noninvasive Contact Lens Sensor Detects Tear Serotonin for Stress Assessment

Stress-related physiological changes can be difficult to monitor objectively over time. Serotonin plays a role in mood regulation and stress physiology and is also present in tears, providing a minimally... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.